Exploración Integral de la Enfermedad de Huntington en Juan de Acosta, Colombia: Perspectivas Históricas, Neuropsicológicas, Genéticas y Neuroanatómicas. Estudiante: Mostapha Ahmad Código: 2018255899319 Tesis Doctoral presentada como requisito para optar el título de: Doctor en Genética y Biología Molecular Tutor(es): Johan Acosta Psicólogo, Neuropsicología, PhD en Psicología con Orientación en Neurociencias Cognitivas Aplicadas Resumen La presente tesis ofrece un análisis exhaustivo de la Enfermedad de Huntington (EH) en Juan de Acosta, Colombia, abordando cuatro componentes clave: neuropsicológico, genético, neuroanatómico e histórico. El componente histórico abordó el "Efecto Fundador" de la EH en Juan de Acosta, explorando la ascendencia vasca, la migración durante la colonización española y la conexión entre datos genealógicos y la prevalencia de EH. Se resaltó la relevancia de la subestructura interna en la población vasca y la existencia de mutaciones fundacionales. Desde la perspectiva neuropsicológica, se identificaron marcadores tempranos en la EH mediante pruebas específicas, como la copia de la figura del rey y la prueba Stroop. Individuos en fase premotora mostraron alteraciones significativas en habilidades visoconstructivas e inhibición cognitiva, sugiriendo su potencial como marcadores tempranos de disfunción neurocognitiva. En el componente genético, se realizó el análisis genómico de 291 individuos reveló repeticiones CAG en el gen huntingtina (HTT), destacando los alelos 17/7 y 17/10 como los más comunes y evidenciando un aumento de mosaicismo con la edad. La investigación neuroanatómica se centró en alteraciones volumétricas cerebrales en individuos premanifiestos, identificando cambios significativos, como la disminución del volumen del parénquima cerebral en la penetrancia completa y hallazgos sorprendentes en el grupo intermedio. La dilatación ventricular emergió como un indicador potencial de la progresión global de la enfermedad. En conjunto, esta tesis proporciona una visión completa de la EH en Juan de Acosta, integrando aspectos neuropsicológicos, genéticos, neuroanatómicos e históricos. Estos hallazgos no solo enriquecen la comprensión de la enfermedad, sino que también tienen implicaciones cruciales para la detección temprana, intervenciones preventivas y gestión clínica en esta población. Palabras clave Premotores EH, habilidades visoconstructivas, inhibición, marcadores tempranos, Enfermedad de Huntington, HTT, repeticiones CAG, mosaicismo, deslizamiento, EH premanifiesta, biomarcadores, cambios volumétricos cerebrales, dilatación ventricular, Efecto Fundador, ascendencia vasca, migración colonial, datos genealógicos, prevalencia diferencial Abstract This thesis presents a comprehensive analysis of Huntington's Disease (HD) in Juan de Acosta, Colombia, addressing four key components: neuropsychological, genetic, neuroanatomical, and historical. The historical component delved into the "Founder Effect" of HD in Juan de Acosta, exploring Basque ancestry, migration during Spanish colonization, and the connection between genealogical data and HD prevalence. The relevance of internal substructure in the Basque population and the existence of founder mutations were emphasized. From a neuropsychological perspective, early markers in HD were identified through specific tests such as the King's figure copy and the Stroop test. Individuals in the premanifest phase showed significant alterations in visuospatial skills and cognitive inhibition, suggesting their potential as early markers of neurocognitive dysfunction. In the genetic component, genomic analysis of 291 individuals revealed CAG repeats in the huntingtin gene (HTT), highlighting the 17/7 and 17/10 alleles as the most common and showing an increase in mosaicism with age. Neuroanatomical research focused on brain volumetric alterations in premanifest individuals, identifying significant changes such as decreased cerebral parenchymal volume in complete penetrance and surprising findings in the intermediate group. Ventricular dilation emerged as a potential indicator of overall disease progression. Overall, this thesis provides a comprehensive view of HD in Juan de Acosta, integrating neuropsychological, genetic, neuroanatomical, and historical aspects. These findings not only enrich the understanding of the disease but also have crucial implications for early detection, preventive interventions, and clinical management in this population. Keywords Premanifest HD, visuospatial skills, early markers, Huntington's disease, CAG repeats, mosaicism, slippage, premanifest HD, biomarkers, brain volumetric changes, ventricular dilation, Founder Effect, Basque ancestry, colonial migration, genealogical data, differential prevalence. REFERENCIAS BIBLIOGRÁFICAS A worldwide study of the HD mutation. (1994). Abeyasinghe, P. M., Long, J. D., Razi, A., Pustina, D., Paulsen, J. S., Tabrizi, S. J., Poudel, G. R., & Georgiou-Karistianis, N. (2021). Tracking Huntingtonʼs Disease Progression Using Motor, Functional, Cognitive, and Imaging Markers. Movement Disorders, 36(10), 2282–2292. https://doi.org/10.1002/mds.28650 Agostinho, L. D. A., Rocha, C. F., Medina-Acosta, E., Barboza, H. N., Da Silva, A. F. A., Pereira, S. P. F., Da Silva, I. D. S., Paradela, E. R., Figueiredo, A. L. D. S., Nogueira, E. D. M., Alvarenga, R. M. P., Hernan Cabello, P., Dos Santos, S. R., & Paiva, C. L. A. (2012). Haplotype analysis of the CAG and CCG repeats in 21 Brazilian families with Huntington’s disease. Journal of Human Genetics, 57(12), 796–803. https://doi.org/10.1038/jhg.2012.120 Aguirre, A., Vicario, A., Mazón, L. I., Estomba, A., Martínez De Pancorbo, M., Arrieta Picó, V., Perez Elortondo, F., & Lostao, C. M. (1991). Are the Basques a single and a unique population? American Journal of Human Genetics, 49(2), 450–458. Ahmad, M., Ríos-Anillo, M. R., Acosta-López, J. E., Cervantes-Henríquez, M. L., Martínez-Banfi, M., Pineda-Alhucema, W., Puentes-Rozo, P., Sánchez-Barros, C., Pinzón, A., Patel, H. R., Vélez, J. I., Villarreal-Camacho, J. L., Pineda, D. A., Arcos- Burgos, M., & Sánchez-Rojas, M. (2023). Uncovering the Genetic and Molecular Features of Huntington’s Disease in Northern Colombia. International Journal of Molecular Sciences, 24(22). https://doi.org/10.3390/ijms242216154 Al-Eitan, L. N., Rababa’h, D. M., Hakooz, N. M., Alghamdi, M. A., & Dajani, R. B. (2020). Genetic polymorphisms of pharmacogenes among the genetically isolated circassian subpopulation from jordan. Journal of Personalized Medicine, 10(1). https://doi.org/10.3390/jpm10010002 Alfonso, H. S. (1996). Caracterización de las secuencias polimórficas de tripletes CAG y CCG del gen de la enfermedad de Huntington en familias colombianas. Acta Méd Colomb, 12, 70–75. Alonso, S., Flores, C., Cabrera, V., Alonso, A., Martín, P., Albarrán, C., Izagirre, N., de la Rúa, C., & García, O. (2005). The place of the Basques in the European Y- chromosome diversity landscape. European Journal of Human Genetics, 13(12), 1293–1302. https://doi.org/10.1038/sj.ejhg.5201482 Amedi, A., Jacobson, G., Hendler, T., Malach, R., & Zohary, E. (2002). Convergence of visual and tactile shape processing in the human lateral occipital complex. Cerebral Cortex, 12(11), 1202–1212. Apolinário, T. A., da Silva, I. dos S., Agostinho, L. de A., & Paiva, C. L. A. (2020). Investigation of intermediate CAG alleles of the HTT in the general population of Rio de Janeiro, Brazil, in comparison with a sample of Huntington disease-affected families. Molecular Genetics and Genomic Medicine, 8(4), 1–8. https://doi.org/10.1002/mgg3.1181 Arango-Lasprilla, J. C., Iglesias-Dorado, J., & Lopera, F. (2003). Características clínicas y neuropsicológicas de la enfermedad de Huntington: Una revisiónrevision. Revista de Neurologia, 37(8), 758–765. https://doi.org/10.33588/rn.3708.2003010 Arcos-Burgos, M., & Muenke, M. (2002). Genetics of population isolates. Clinical Genetics, 61(4), 233–247. https://doi.org/10.1034/j.1399-0004.2002.610401.x Astafiev, S. V, Stanley, C. M., Shulman, G. L., & Corbetta, M. (2004). Extrastriate body area in human occipital cortex responds to the performance of motor actions. Nature Neuroscience, 7(5), 542–548. Aylward, E. H., Anderson, N. B., Bylsma, F. W., Wagster, M. V, Barta, P. E., Sherr, M., Feeney, J., Davis, A., Rosenblatt, A., Pearlson, G. D., & Ross, C. A. (1998). Frontal lobe volume in patients with Huntington’s disease. Neurology, 50(1), 252–258. https://doi.org/10.1212/wnl.50.1.252 Baeta, M., Nunez, C., Cardoso, S., Palencia-Madrid, L., Pineiro-Hermida, S., Arriba- Barredo, M., Villanueva-Millan, M. J., & De Pancorbo, M. M. (2015). Different Evolutionary History for Basque Diaspora Populations in USA and Argentina Unveiled by Mitochondrial DNA Analysis. PLoS ONE, 10(12), 1–13. https://doi.org/10.1371/journal.pone.0144919 Baizer, J. S., Desimone, R., & Ungerleider, L. G. (1993). Comparison of subcortical connections of inferior temporal and posterior parietal cortex in monkeys. Visual Neuroscience, 10(1), 59–72. Bamshad, M., & Wooding, S. P. (2003). Signatures of natural selection in the human genome. Nature Reviews Genetics, 4(2), 99–110. https://doi.org/10.1038/nrg999 Bauduer, F. (2008). [History of biological anthropology of the Basque population: empiricism with molecular genetics]. Histoire des sciences medicales, 42(2), 123– 130. Bauduer, F., Feingold, J., & Lacombe, D. (2005). The Basques: review of population genetics and Mendelian disorders. Human Biology, 77(5), 619–637. https://doi.org/10.1353/hub.2006.0001 Binder, L. M. (1982). Constructional strategies on complex figure drawings after unilateral brain damage. Journal of Clinical Neuropsychology, 4(1), 51–58. https://doi.org/10.1080/01688638208401116 Bourgain, C., & Génin, E. (2005). Complex trait mapping in isolated populations: Are specific statistical methods required? European Journal of Human Genetics, 13(6), 698–706. https://doi.org/10.1038/sj.ejhg.5201400 Bradley, I. M., Pinto, A. J., & Guest, J. S. (2016). Gene-Specific Primers for Improved Characterization of Mixed Phototrophic Communities. Applied and Environmantal Microbiology, 82(19), 5878–5891. https://doi.org/10.1128/AEM.01630-16.Editor Braisch, U., Muche, R., Rothenbacher, D., Landwehrmeyer, G. B., Long, J. D., & Orth, M. (2019). Identification of symbol digit modality test score extremes in Huntington’s disease. American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics, 180(3), 232–245. https://doi.org/10.1002/ajmg.b.32719 Brand, A., Bradley, M. T., Best, L. A., & Stoica, G. (2008). Accuracy of effect size estimates from published psychological research. Percept Mot Skills, 106(2), 645–649. https://doi.org/10.2466/pms.106.2.645-649 Brandt, J., Shpritz, B., Munro, C. A., Marsh, L., & Rosenblatt, A. (2005). Differential impairment of spatial location memory in Huntington’s disease. Journal of Neurology, Neurosurgery and Psychiatry, 76(11), 1516–1519. https://doi.org/10.1136/jnnp.2004.059253 Burgess, N., Maguire, E. A., & O’Keefe, J. (2002). The human hippocampus and spatial and episodic memory. Neuron, 35(4), 625–641. Burrell, A. S., & Disotell, T. R. (2009). Panmixia postponed: Ancestry-related assortative mating in contemporary human populations. Genome Biology, 10(11). https://doi.org/10.1186/gb-2009-10-11-245 Burton, A. (2013). Hope, humanity, and Huntington’s disease in Latin America. The Lancet Neurology, 12(2), 133–134. https://doi.org/10.1016/S1474-4422(13)70006-1 Calafell, F., & Bertranpetit, J. (1994a). Mountains and genes: population history of the Pyrenees. Human Biology, 66(5), 823–842. Calafell, F., & Bertranpetit, J. (1994b). Principal component analysis of gene frequencies and the origin of Basques. American Journal of Physical Anthropology, 93(2), 201– 215. https://doi.org/10.1002/ajpa.1330930205 Carella, F., Bressanelli, M., Piacentini, S., Soliveri, P., Geminiani, G., Monza, D., Albanese, A., & Girotti, F. (2003). A study of arm movements in Huntington’s disease under visually controlled and blindfolded conditions. Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 23(6), 287–293. https://doi.org/10.1007/s100720300003 Carlozzi, N. E., Stout, J. C., Mills, J. A., Duff, K., Beglinger, L. J., Aylward, E. H., Whitlock, K. B., Solomon, A. C., Queller, S., Langbehn, D. R., Johnson, S. A., & Paulsen, J. S. (2011). Estimating premorbid IQ in the prodromal phase of a neurodegenerative disease. The Clinical Neuropsychologist, 25(5), 757–777. https://doi.org/10.1080/13854046.2011.577811 Casella, C., Lipp, I., Rosser, A., Jones, D. K., & Metzler-Baddeley, C. (2020). A Critical Review of White Matter Changes in Huntington’s Disease. Movement Disorders : Official Journal of the Movement Disorder Society, 35(8), 1302–1311. https://doi.org/10.1002/mds.28109 Castilla, E. E., & Adams, J. (1996). Genealogical information and the structure of rural Latin-American populations: reality and fantasy. Human Heredity, 46(5), 241–255. https://doi.org/10.1159/000154361 Castro, M. De, & Restrepo, C. M. (2015). Genetics and genomic medicine in colombia. Molecular Genetics and Genomic Medicine, 3(2), 84–91. https://doi.org/10.1002/mgg3.139 Ceccarini, J., Ahmad, R., Van De Vliet, L., Casteels, C., Vandenbulcke, M., Vandenberghe, W., & Van Laere, K. (2019). Behavioral symptoms in premanifest Huntington disease correlate with reduced frontal CB 1 R levels. Journal of Nuclear Medicine, 60(1), 115–121. https://doi.org/10.2967/jnumed.118.210393 Ciosi, M., Cumming, S., Alshammari, A., Symeonidi, E., Herzyk, P., McGuinness, D., Galbraith, J., Hamilton, G., & Monckton, D. (2020). Library preparation and MiSeq sequencing for the genotyping-by-sequencing of the Huntington disease HTT exon one trinucleotide repeat and the quantification of somatic mosaicism. https://doi.org/10.21203/rs.2.1581/v2 Clever, F., Cho, I. K., Yang, J., & Chan, A. W. S. (2019). Progressive Polyglutamine Repeat Expansion in Peripheral Blood Cells and Sperm of Transgenic Huntington’s Disease Monkeys. Journal of Huntington’s Disease, 8(4), 443–448. https://doi.org/10.3233/JHD-190359 Cohen, J. (1988). Statistical Power Analysis for the Behavioral Sciences. Hillsdle. Erlbaum. Conner, BE (1988). The Box in the Barn. Columbus: Highlights for …. Coppen, E. M., Jacobs, M., van der Zwaan, K. F., Middelkoop, H. A. M., & Roos, R. A. C. (2019). Visual Object Perception in Premanifest and Early Manifest Huntington’s Disease. Archives of Clinical Neuropsychology : The Official Journal of the National Academy of Neuropsychologists, 34(8), 1320–1328. https://doi.org/10.1093/arclin/acz002 Coppen, E. M., van der Grond, J., Hart, E. P., Lakke, E. A. J. F., & Roos, R. A. C. (2018). The visual cortex and visual cognition in Huntington’s disease: An overview of current literature. Behavioural Brain Research, 351, 63–74. https://doi.org/10.1016/j.bbr.2018.05.019 Cuevas-Guarnizo, A. (2014). La enfermedad rara más común en Juan de Acosta. El Espectador. DANE. (2019). Resultados Censo Nacional de Población y Vivienda 2018 Sogamoso, Tunja, Boyacá. 27. Daza, J., Carbonell, C., & B. A. (1995). Correlación clínico-molecular y caracterización de la enfermedad de Huntington en familias de Juan de Acosta y otras regiones colombianas. 4., 300–321. Daza B, Caiaffa RH, Arteta BJV, Echevarría RV, E. M. & A. R. (1991). Estudio neuroepidemiológico enJuandeAcosta,Atlántico,Colombia. ActaMédCoI, 17, 324. Daza, B., Caiaffa, R. H., Arteta, B. J., Echeverría, R. V, Ladrón de Guevara, Z., & Escamilla, M. (1992). Estudio neuroepidemiológico en Juan de Acosta, Atlántico, Colombia. Acta Med Colomb, 17, 324. Daza J., Carbonell, C., Brokate A., & Caiaffa H. (1996). Caracterización de las secuencias polimórficas de tripletas CAG y CCG del gen de la enfermedad de Huntington en familias colombianas. Acta Neurologica Colombiana, 12., 70–75. De Castro, M., & Restrepo, C. M. (2015). Genetics and genomic medicine in Colombia. Mol Genet Genomic Med, 3(2), 84–91. https://doi.org/10.1002/mgg3.139 Departamento Administrativo Nacional de Estadistica (DANE). (2007). Colombia una Nación Multicultural. Colombia Una Nación Multicultural, Su Diversidad Étnica, 1– 45. Dhalla, A., Pallikadavath, S., & Hutchinson, C. V. (2019). Visual Dysfunction in Huntington’s Disease: A Systematic Review. Journal of Huntington’s Disease, 8(2), 233–242. https://doi.org/10.3233/JHD-180340 Divac, I., Rosvold, H. E., & Szwarcbart, M. K. (1967). Behavioral effects of selective ablation of the caudate nucleus. Journal of Comparative and Physiological Psychology, 63(2), 184. Eddy, C. M., & Rickards, H. E. (2015). Cognitive deficits predict poorer functional capacity in Huntington’s disease: but what is being measured? Neuropsychology, 29(2), 268–273. https://doi.org/10.1037/neu0000134 Epping, E. A., Kim, J.-I., Craufurd, D., Brashers-Krug, T. M., Anderson, K. E., McCusker, E., Luther, J., Long, J. D., & Paulsen, J. S. (2016). Longitudinal Psychiatric Symptoms in Prodromal Huntington’s Disease: A Decade of Data. The American Journal of Psychiatry, 173(2), 184–192. https://doi.org/10.1176/appi.ajp.2015.14121551 Etcheverry, M. A. (1945). El factor rhesus su genetica e importancia clinica. El Dia medico, 17, 1237–1251. Fadrosh, D. W., Ma, B., Gajer, P., Sengamalay, N., Ott, S., Brotman, R. M., & Ravel, J. (2014). An improved dual-indexing approach for multiplexed 16S rRNA gene sequencing on the Illumina MiSeq platform. Microbiome, 2(1), 1–7. https://doi.org/10.1186/2049-2618-2-6 Fennema-Notestine, C., Archibald, S. L., Jacobson, M. W., Corey-Bloom, J., Paulsen, J. S., Peavy, G. M., Gamst, A. C., Hamilton, J. M., Salmon, D. P., & Jernigan, T. L. (2004). In vivo evidence of cerebellar atrophy and cerebral white matter loss in Huntington disease. Neurology, 63(6), 989–995. https://doi.org/10.1212/01.wnl.0000138434.68093.67 Fielding, J., Georgiou-Karistianis, N., Millist, L., & White, O. (2006). Temporal variation in the control of goal-directed visuospatial attention in basal ganglia disorders. Neuroscience Research, 54(1), 57–65. Finke, K., Bublak, P., Dose, M., Müller, H. J., & Schneider, W. X. (2006). Parameter-based assessment of spatial and non-spatial attentional deficits in Huntington’s disease. Brain : A Journal of Neurology, 129(Pt 5), 1137–1151. https://doi.org/10.1093/brain/awl040 Franco-Giraldo, Á. (2012). La última reforma del sistema general de seguridad social en salud colombiano. Revista de Salud Pública, 14, 865–877. FUNPEHUJAC. (2004). Fundacion por Pacientes con la Enfermedad de Huntington en Juan de Acosta. Unpublishe, [Proposal for the first conference for Colombian’s. Garcia-Gorro, C., Llera, A., Martinez-Horta, S., Perez-Perez, J., Kulisevsky, J., Rodriguez- Dechicha, N., Vaquer, I., Subira, S., Calopa, M., Muñoz, E., Santacruz, P., Ruiz- Idiago, J., Mareca, C., Beckmann, C. F., de Diego-Balaguer, R., & Camara, E. (2019). Specific patterns of brain alterations underlie distinct clinical profiles in Huntington’s disease. NeuroImage. Clinical, 23, 101900. https://doi.org/10.1016/j.nicl.2019.101900 Gauvin, H., Lefebvre, J. F., Moreau, C., Lavoie, E. M., Labuda, D., Vézina, H., & Roy- Gagnon, M. H. (2015). GENLIB: An R package for the analysis of genealogical data. BMC Bioinformatics, 16(1), 1–10. https://doi.org/10.1186/s12859-015-0581-5 Gerovska, D., Irizar, H., Otaegi, D., Ferrer, I., López de Munain, A., & Araúzo-Bravo, M. J. (2020). Genealogy of the neurodegenerative diseases based on a meta-analysis of age-stratified incidence data. Scientific Reports, 10(1), 18923. https://doi.org/10.1038/s41598-020-75014-8 Glangetas, C., Espinosa, P., & Bellone, C. (2020). Deficit in Motor Skill Consolidation- Dependent Synaptic Plasticity at Motor Cortex to Dorsolateral Striatum Synapses in a Mouse Model of Huntington’s Disease. ENeuro, 7(2). https://doi.org/10.1523/ENEURO.0297-19.2020 Gómez-Ansón, B., Alegret, M., Muñoz, E., Monté, G. C., Alayrach, E., Sánchez, A., Boada, M., & Tolosa, E. (2009). Prefrontal cortex volume reduction on MRI in preclinical Huntington’s disease relates to visuomotor performance and CAG number. Parkinsonism & Related Disorders, 15(3), 213–219. https://doi.org/10.1016/j.parkreldis.2008.05.010 Gómez-Tortosa, E., del Barrio, A., Barroso, T., & García Ruiz, P. J. (1996). Visual processing disorders in patients with Huntington’s disease and asymptomatic carriers. Journal of Neurology, 243(3), 286–292. https://doi.org/10.1007/BF00868528 Gorrochategui, J. (2002). Plant eamient os de la lingüíst ica hist órica en la dat ación del Euskara. Gregory, S., Scahill, R. I., Rees, G., & Tabrizi, S. (2018a). Magnetic resonance imaging in Huntington’s disease. Methods in Molecular Biology, 1780, 303–328. https://doi.org/10.1007/978-1-4939-7825-0_16 Gregory, S., Scahill, R. I., Rees, G., & Tabrizi, S. (2018b). Magnetic Resonance Imaging in Huntington’s Disease BT - Huntington’s Disease (S. V Precious, A. E. Rosser, & S. B. Dunnett (Eds.); pp. 303–328). Springer New York. https://doi.org/10.1007/978-1- 4939-7825-0_16 Gusella, J. F., & MacDonald, M. E. (2006). Huntington’s disease: seeing the pathogenic process through a genetic lens. Trends in Biochemical Sciences, 31(9), 533–540. https://doi.org/10.1016/j.tibs.2006.06.009 Gusella, J. F., & MacDonald, M. E. (2009). Huntington’s disease: the case for genetic modifiers. Genome Medicine, 1(8), 80. https://doi.org/10.1186/gm80 Ha, A. D., & Fung, V. S. C. (2012). Huntington’s disease. Current Opinion in Neurology, 25(4), 491–498. https://doi.org/10.1097/WCO.0b013e3283550c97 Harris, K. L., Armstrong, M., Swain, R., Erzinclioglu, S., Das, T., Burgess, N., Barker, R. A., & Mason, S. L. (2019). Huntington’s disease patients display progressive deficits in hippocampal-dependent cognition during a task of spatial memory. Cortex; a Journal Devoted to the Study of the Nervous System and Behavior, 119, 417–427. https://doi.org/10.1016/j.cortex.2019.07.014 Hayden Berkowicz, AL, Beighton, PH & Yiptong, C, M. R. (1981). Huntington’s chorea on the island of Mauritius. South African Medical Journal, 60(26), 1001–1002. Heindel, W. C., Butters, N., & Salmon, D. P. (1988). Impaired learning of a motor skill in patients with Huntington’s disease. Behavioral Neuroscience, 102(1), 141–147. https://doi.org/10.1037//0735-7044.102.1.141 Heutink, P., & Oostra, B. A. (2002). Gene finding in genetically isolated populations. Human Molecular Genetics, 11(20), 2507–2515. https://doi.org/10.1093/hmg/11.20.2507 Hobbs, N. Z., Barnes, J., Frost, C., Henley, S. M. D., Wild, E. J., Macdonald, K., Barker, R. A., Scahill, R. I., Fox, N. C., & Tabrizi, S. J. (2010). Onset and progression of pathologic atrophy in Huntington disease: a longitudinal MR imaging study. AJNR. American Journal of Neuroradiology, 31(6), 1036–1041. https://doi.org/10.3174/ajnr.A2018 Ihaka, R., & Gentleman, R. (1996). R: A Language for Data Analysis and Graphics. Journal of Computational and Graphical Statistics, 5(3), 299–314. https://doi.org/10.2307/1390807 Iriondo, M., Barbero, M. C., & Manzano, C. (2003). DNA polymorphisms detect ancient barriers to gene flow in Basques. American Journal of Physical Anthropology, 122(1), 73–84. https://doi.org/10.1002/ajpa.10212 Jensen, R. N., Bolwig, T., & Sørensen, S. A. (2018). [Psychiatric symptoms in patients with Huntington’s disease]. Ugeskrift for laeger, 180(13). Johnson, E. B., Rees, E. M., Labuschagne, I., Durr, A., Leavitt, B. R., Roos, R. A. C., Reilmann, R., Johnson, H., Hobbs, N. Z., Langbehn, D. R., Stout, J. C., Tabrizi, S. J., & Scahill, R. I. (2015). The impact of occipital lobe cortical thickness on cognitive task performance: An investigation in Huntington’s Disease. Neuropsychologia, 79(Pt A), 138–146. https://doi.org/10.1016/j.neuropsychologia.2015.10.033 Jorde, L. B., Watkins, W. S., Kere, J., Nyman, D., & Eriksson, A. W. (2000). Gene mapping in isolated populations: new roles for old friends? Human Heredity, 50(1), 57–65. https://doi.org/10.1159/000022891 Jorde, L. B., & Wooding, S. P. (2004). Genetic variation, classification and {\textquoteleft}race{\textquoteright}. Nature Genetics, 36(11), 1–6. https://doi.org/10.1034/ng1435 Kandt, J., & Longley, P. A. (2018). Ethnicity estimation using family naming practices. PLOS ONE, 13(8), e0201774. Kay, C., Hayden, M. R., & Leavitt, B. R. (2017). Epidemiology of Huntington disease. Handbook of Clinical Neurology, 144, 31–46. https://doi.org/10.1016/B978-0-12- 801893-4.00003-1 Khan, W., Alusi, S., Tawfik, H., & Hussain, A. (2021). The relationship between non- motor features and weight-loss in the premanifest stage of Huntington’s disease. PLOS ONE, 16(7), 1–24. https://doi.org/10.1371/journal.pone.0253817 Kim, A., Lalonde, K., Truesdell, A., Gomes Welter, P., Brocardo, P. S., Rosenstock, T. R., & Gil-Mohapel, J. (2021). New Avenues for the Treatment of Huntington’s Disease. International Journal of Molecular Sciences, 22(16). https://doi.org/10.3390/ijms22168363 Kremer, H. P. H., & Group, H. S. (1996). Unified Huntington’s disease rating scale: reliability and consistency. Movement Disorders, 11, 136–142. Kristiansson, K., Naukkarinen, J., & Peltonen, L. (2008). Isolated populations and complex disease gene identification. Genome Biology, 9(8), 1–9. https://doi.org/10.1186/gb- 2008-9-8-109 Laayouni, H., Calafell, F., & Bertranpetit, J. (2010). A genome-wide survey does not show the genetic distinctiveness of Basques. Human Genetics, 127(4), 455–458. https://doi.org/10.1007/s00439-010-0798-3 Langbehn, D. R., Brinkman, R. R., Falush, D., Paulsen, J. S., Hayden, M. R., & Group, an I. H. D. C. (2004). A new model for prediction of the age of onset and penetrance for Huntington’s disease based on CAG length. Clinical Genetics, 65(4), 267–277. Langbehn, D. R., Stout, J. C., Gregory, S., Mills, J. A., Durr, A., Leavitt, B. R., Roos, R. A. C., Long, J. D., Owen, G., Johnson, H. J., Borowsky, B., Craufurd, D., Reilmann, R., Landwehrmeyer, G. B., Scahill, R. I., & Tabrizi, S. J. (2019). Association of CAG Repeats With Long-term Progression in Huntington Disease. JAMA Neurology, 76(11), 1375–1385. https://doi.org/10.1001/jamaneurol.2019.2368 Larmuseau, M. H. D., Ottoni, C., Raeymaekers, J. A. M., Vanderheyden, N., Larmuseau, H. F. M., & Decorte, R. (2012). Temporal differentiation across a West-European Y- chromosomal cline: Genealogy as a tool in human population genetics. European Journal of Human Genetics, 20(4), 434–440. https://doi.org/10.1038/ejhg.2011.218 Larsson, J., & Heeger, D. J. (2006). Two retinotopic visual areas in human lateral occipital cortex. Journal of Neuroscience, 26(51), 13128–13142. https://doi.org/10.1523/JNEUROSCI.1657-06.2006 Lawrence, A. D., Watkins, L. H. A., Sahakian, B. J., Hodges, J. R., & Robbins, T. W. (2000). Visual object and visuospatial cognition in Huntington’s disease: implications for information processing in corticostriatal circuits. Brain, 123(7), 1349–1364. https://doi.org/10.1093/brain/123.7.1349 Lee, S.-Y., Yoon, S.-Y., Kim, M.-J., Rhee, H., Ryu, C., & Jahng, G.-H. (2013). Investigation of the Correlation between Seoul Neuropsychological Screening Battery Scores and the Gray Matter Volume after Correction of Covariates of the Age, Gender, and Genotypes in Patients with AD and MCI. Journal of the Korean Society of Magnetic Resonance in Medicine, 17, 294. https://doi.org/10.13104/jksmrm.2013.17.4.294 Lemay, M., Fimbel, E., Beuter, A., Chouinard, S., & Richer, F. (2005). Sensorimotor mapping affects movement correction deficits in early Huntington’s disease. Experimental Brain Research, 165(4), 454–460. https://doi.org/10.1007/s00221-005- 2315-9 Liascovich, R., Rittler, M., & Castilla, E. E. (2001). Consanguinity in South America: demographic aspects. Human Heredity, 51(1–2), 27–34. https://doi.org/10.1159/000022956 Linares Gómez Andrea. (2009). Por causa de gen maligno, un pueblo debe evitar reproducirse. ESPECIAL DE EL TIEMPO. Liu, H., Zhang, C., Xu, J., Jin, J., Cheng, L., Miao, X., Wu, Q., Wei, Z., Liu, P., Lu, H., van Zijl, P. C. M., Ross, C. A., Hua, J., & Duan, W. (2021). Huntingtin silencing delays onset and slows progression of Huntington’s disease: a biomarker study. Brain : A Journal of Neurology, 144(10), 3101–3113. https://doi.org/10.1093/brain/awab190 Lo, J., Reyes, A., Pulverenti, T. S., Rankin, T. J., Bartlett, D. M., Zaenker, P., Rowe, G., Feindel, K., Poudel, G., Georgiou-Karistianis, N., Ziman, M. R., & Cruickshank, T. M. (2020). Dual tasking impairments are associated with striatal pathology in Huntington’s disease. Annals of Clinical and Translational Neurology, 7(9), 1608– 1619. https://doi.org/10.1002/acn3.51142 MacDonald, M. E., Ambrose, C. M., Duyao, M. P., Myers, R. H., Lin, C., Srinidhi, L., Barnes, G., Taylor, S. A., James, M., Groot, N., MacFarlane, H., Jenkins, B., Anderson, M. A., Wexler, N. S., Gusella, J. F., Bates, G. P., Baxendale, S., Hummerich, H., Kirby, S., … Harper, P. S. (1993). A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell, 72(6), 971–983. https://doi.org/10.1016/0092-8674(93)90585-E Maestre, R., Bermúdez, A., Ching, R., Mejía, G., Malambo, D., & Gómez, D. (2010). Diagnóstico molecular de la Enfermedad de Huntington en el departamento del Atlántico , Colombia (2009). Iatreia, 23(4-S SE-Resúmenes). Marchina, E., Misasi, S., Bozzato, A., Ferraboli, S., Agosti, C., Rozzini, L., Borsani, G., Barlati, S., & Padovani, A. (2014). Gene expression profile in fibroblasts of Huntington’s disease patients and controls. Journal of the Neurological Sciences, 337(1–2), 42–46. https://doi.org/10.1016/j.jns.2013.11.014 Martínez-Horta, S., Horta-Barba, A., Perez-Perez, J., Antoran, M., Pagonabarraga, J., Sampedro, F., & Kulisevsky, J. (2020). Impaired face-like object recognition in premanifest Huntington’s disease. Cortex; a Journal Devoted to the Study of the Nervous System and Behavior, 123, 162–172. https://doi.org/10.1016/j.cortex.2019.10.015 Martinez-Horta, S., Sampedro, F., Horta-Barba, A., Perez-Perez, J., Pagonabarraga, J., Gomez-Anson, B., & Kulisevsky, J. (2020). Structural brain correlates of dementia in Huntington’s disease. NeuroImage. Clinical, 28, 102415. https://doi.org/10.1016/j.nicl.2020.102415 Masuda, N., Goto, J., Murayama, N., Watanabe, M., Kondo, I., & Kanazawa, I. (1995). Analysis of triplet repeats in the huntingtin gene in Japanese families affected with Huntington’s disease. Journal of Medical Genetics, 32(9), 701–705. https://doi.org/10.1136/jmg.32.9.701 Maxwell, A. (2022). ScaleHD Documentation. McColgan, P., Gregory, S., Seunarine, K. K., Razi, A., Papoutsi, M., Johnson, E., Durr, A., Roos, R. A. C., Leavitt, B. R., Holmans, P., Scahill, R. I., Clark, C. A., Rees, G., & Tabrizi, S. J. (2018). Brain Regions Showing White Matter Loss in Huntington’s Disease Are Enriched for Synaptic and Metabolic Genes. Biological Psychiatry, 83(5), 456–465. https://doi.org/10.1016/j.biopsych.2017.10.019 Mishkin, M., Lewis, M. E., & Ungerleider, L. G. (1982). Equivalence of parieto- preoccipital subareas for visuospatial ability in monkeys. Behavioural Brain Research, 6(1), 41–55. Mishkin, M., & Ungerleider, L. G. (1982). Contribution of striate inputs to the visuospatial functions of parieto-preoccipital cortex in monkeys. Behavioural Brain Research, 6(1), 57–77. Misnaza Castrillon, S. P., & Armenta-Restrepo, A. (2017). Indice modificado de esfuerzo en cuidadores informales de personas con Enfermedad de Huntington en los Municipios de Algarrobo, Ariguani y San Angel. Magdalena, Colombia. Rev. Med. Risaralda, 3–7. Mohr, E., Brouwers, P., Claus, J. J., Mann, U., Fedio, P., & Chase, T. (1991). Visuospatial cognition in Huntington’s disease. Movement Disorders, 6. Moses, J. A., Golden, C. J., Berger, P. A., & Wisniewski, A. M. (1981). Neuropsychological Deficits in Early, Middle, and Late Stage Huntington’s Disease as Measured by the Luria-Nebraska Neuropsychological Battery. International Journal of Neuroscience, 14(1–2), 95–100. https://doi.org/10.3109/00207458108985820 Myers, R. H. (2004). Huntington’s disease genetics. NeuroRx : The Journal of the American Society for Experimental NeuroTherapeutics, 1(2), 255–262. https://doi.org/10.1602/neurorx.1.2.255 Myers, R. H., Vonsattel, J. P., Stevens, T. J., Cupples, L. A., Richardson, E. P., Martin, J. B., & Bird, E. D. (1988). Clinical and neuropathologic assessment of severity in Huntington’s disease. Neurology, 38(3), 341. Nanetti, L., Contarino, V. E., Castaldo, A., Sarro, L., Bachoud-Levi, A.-C., Giavazzi, M., Frittoli, S., Ciammola, A., Rizzo, E., Gellera, C., Bruzzone, M. G., Taroni, F., Grisoli, M., & Mariotti, C. (2018). Cortical thickness, stance control, and arithmetic skill: An exploratory study in premanifest Huntington disease. Parkinsonism & Related Disorders, 51, 17–23. https://doi.org/10.1016/j.parkreldis.2018.02.033 Newman, D. L., Abney, M., McPeek, M. S., Ober, C., & Cox, N. J. (2001). The Importance of Genealogy in Determining Genetic Associations with Complex Traits. The American Journal of Human Genetics, 69(5), 1146–1148. https://doi.org/10.1086/323659 Nopoulos, P. C., Aylward, E. H., Ross, C. A., Johnson, H. J., Magnotta, V. A., Juhl, A. R., Pierson, R. K., Mills, J., Langbehn, D. R., & Paulsen, J. S. (2010). Cerebral cortex structure in prodromal Huntington disease. Neurobiology of Disease, 40(3), 544–554. https://doi.org/10.1016/j.nbd.2010.07.014 O’Brien, E., Jorde, L. B., Rönnlöf, B., Fellman, J. O., & Eriksson, A. W. (1988). Inbreeding and genetic disease in Sottunga, Finland. American Journal of Physical Anthropology, 75(4), 477–486. https://doi.org/10.1002/ajpa.1330750405 O’Rourke, J. J. F., Adams, W. H., Duff, K., Byars, J., Nopoulos, P., Paulsen, J. S., & Beglinger, L. J. (2011). Estimating premorbid functioning in huntington’s disease: the relationship between disease progression and the wide range achievement test reading subtest. Archives of Clinical Neuropsychology : The Official Journal of the National Academy of Neuropsychologists, 26(1), 59–66. https://doi.org/10.1093/arclin/acq088 OECD. (2017). Digital technology: Making better use of health data. Olson, S., Berg, K., Bonham, V., Boyer, J., Brody, L., Brooks, L., Collins, F., Guttmacher, A., McEwen, J., Muenke, M., Olson, S., Wang, V. O., Rodriguez, L. L., Vydelingum, N., & Warshauer-Baker, E. (2005). The use of racial, ethnic, and ancestral categories in human genetics research. American Journal of Human Genetics, 77(4), 519–532. https://doi.org/10.1086/491747 Ortega-Leonard, L., Orozco-Calderón, G., Vélez, A., & Cruz, F. (2015). The role of the corpus callosum in the visuospatial processing. Rev. Chil. Neuropsicol, 10(1), 25–30. https://doi.org/10.5839/rcnp.2015.10.01.06 Osterrieth, P. A. (1944). Le test de copie d’une figure complexe; contribution a l’etude de la perception et de la memoire. Archives de Psychologie. Paisán-Ruíz, C., Jain, S., Evans, E. W., Gilks, W. P., Simón, J., van der Brug, M., López de Munain, A., Aparicio, S., Gil, A. M., Khan, N., Johnson, J., Martinez, J. R., Nicholl, D., Martí Carrera, I., Pena, A. S., de Silva, R., Lees, A., Martí-Massó, J. F., Pérez-Tur, J., … Singleton, A. B. (2004). Cloning of the gene containing mutations that cause PARK8-linked Parkinson’s disease. Neuron, 44(4), 595–600. https://doi.org/10.1016/j.neuron.2004.10.023 Palareti, G., Legnani, C., Cosmi, B., Antonucci, E., Erba, N., Poli, D., Testa, S., & Tosetto, A. (2016). Comparison between different D-Dimer cutoff values to assess the individual risk of recurrent venous thromboembolism: Analysis of results obtained in the DULCIS study. International Journal of Laboratory Hematology, 38(1), 42–49. https://doi.org/10.1111/ijlh.12426 Paulsen, J. S. (2011). Cognitive impairment in Huntington disease: diagnosis and treatment. Current Neurology and Neuroscience Reports, 11(5), 474–483. https://doi.org/10.1007/s11910-011-0215-x Paulsen, J. S., Lourens, S., Kieburtz, K., & Zhang, Y. (2019). Sample enrichment for clinical trials to show delay of onset in huntington disease. Movement Disorders : Official Journal of the Movement Disorder Society, 34(2), 274–280. https://doi.org/10.1002/mds.27595 Peña-Casanova, J., Gramunt-Fombuena, N., Quiñones-Úbeda, S., Sánchez-Benavides, G., Aguilar, M., Badenes, D., Molinuevo, J. L., Robles, A., Barquero, M. S., Payno, M., Antúnez, C., Martínez-Parra, C., Frank-García, A., Fernández, M., Alfonso, V., Sol, J. M., & Blesa, R. (2009). Spanish multicenter normative studies (NEURONORMA project): Norms for the rey-osterrieth complex figure (copy and memory), and free and cued selective reminding test. Archives of Clinical Neuropsychology, 24(4), 371–393. https://doi.org/10.1093/arclin/acp041 Peng, C., Zhu, G., Liu, X., & Li, H. (2018). Mutant Huntingtin Causes a Selective Decrease in the Expression of Synaptic Vesicle Protein 2C. Neuroscience Bulletin, 34(5), 747– 758. https://doi.org/10.1007/s12264-018-0230-x Penney, J. B. J., Vonsattel, J. P., MacDonald, M. E., Gusella, J. F., & Myers, R. H. (1997). CAG repeat number governs the development rate of pathology in Huntington’s disease. Annals of Neurology, 41(5), 689–692. https://doi.org/10.1002/ana.410410521 Phillips, W., Shannon, K. M., & Barker, R. A. (2008). The current clinical management of Huntington’s disease. Movement Disorders : Official Journal of the Movement Disorder Society, 23(11), 1491–1504. https://doi.org/10.1002/mds.21971 Pierzynowska, K., Gaffke, L., Cyske, Z., & Węgrzyn, G. (2019). Genistein induces degradation of mutant huntingtin in fibroblasts from Huntington’s disease patients. Metabolic Brain Disease, 34(3), 715–720. https://doi.org/10.1007/s11011-019-00405- 4 Pillon, B. (1981). [Visuo-constructive problems and methods of compensation. Results for 85 patients with brain lesions]. Neuropsychologia, 19(3), 375–383. https://doi.org/10.1016/0028-3932(81)90067-1 Pirogovsky, E., Nicoll, D. R., Challener, D. M., Breen, E., Gluhm, S., Corey‐Bloom, J., & Gilbert, P. E. (2015). The Visual Spatial Learning Test: Differential impairment during the premanifest and manifest stages of Huntington’s disease. Journal of Neuropsychology, 9(1), 77–86. Podvin, S., Reardon, H. T., Yin, K., Mosier, C., & Hook, V. (2019). Multiple clinical features of Huntington’s disease correlate with mutant HTT gene CAG repeat lengths and neurodegeneration. Journal of Neurology, 266(3), 551–564. https://doi.org/10.1007/s00415-018-8940-6 Potter, N. T., Spector, E. B., & Prior, T. W. (2004). Technical Standards and Guidelines for Huntington Disease Testing. Genetics in Medicine, 6(1), 61–65. https://doi.org/10.1097/01.GIM.0000106165.74751.15 Pringsheim, T., Wiltshire, K., Day, L., Dykeman, J., Steeves, T., & Jette, N. (2012). The incidence and prevalence of Huntington’s disease: A systematic review and meta- analysis. Movement Disorders, 27(9), 1083–1091. https://doi.org/10.1002/mds.25075 Pulkes, T., Papsing, C., Wattanapokayakit, S., & Mahasirimongkol, S. (2014). Cag- expansion haplotype analysis in a population with a low prevalence of huntington’s disease. Journal of Clinical Neurology (Korea), 10(1), 32–36. https://doi.org/10.3988/jcn.2014.10.1.32 Purcell, N. L., Goldman, J. G., Ouyang, B., Bernard, B., & O’Keefe, J. A. (2019). The Effects of Dual-Task Cognitive Interference and Environmental Challenges on Balance in Huntington’s Disease. Movement Disorders Clinical Practice, 6(3), 202– 212. https://doi.org/10.1002/mdc3.12720 Rawlins, M. D., Wexler, N. S., Wexler, A. R., Tabrizi, S. J., Douglas, I., Evans, S. J. W., & Smeeth, L. (2016). The Prevalence of Huntington’s Disease. Neuroepidemiology, 46(2), 144–153. https://doi.org/10.1159/000443738 Redondo-Vergé, L. (2001). [Cognitive deterioration in Huntington disease]. Revista de neurologia, 32(1), 82–85. Rey, A. (1941). L’examen psychologique dans les cas d’encéphalopathie traumatique.(Les problems.). Archives de Psychologie. Rey, A. (2009). REY. Test de copia de una figura compleja. TEA Ediciones, Madrid. Risch, N., Choudhry, S., Via, M., Basu, A., Sebro, R., Eng, C., Beckman, K., Thyne, S., Chapela, R., Rodriguez-Santana, J. R., Rodriguez-Cintron, W., Avila, P. C., Ziv, E., & Gonzalez Burchard, E. (2009). Ancestry-related assortative mating in Latino populations. Genome Biology, 10(11). https://doi.org/10.1186/gb-2009-10-11-r132 Rivera, D., Perrin, P. B., Morlett-Paredes, A., Galarza-Del-Angel, J., Martínez, C., Garza, M. T., Saracho, C. P., Rodríguez, W., Rodríguez-Agudelo, Y., Rábago, B., Aliaga, A., Schebela, S., Luna, M., Longoni, M., Ocampo-Barba, N., Fernández, E., Esenarro, L., García-Egan, P., & Arango-Lasprilla, J. C. (2015). Rey-Osterrieth Complex Figure- copy and immediate recall: Normative data for the Latin American Spanish speaking adult population. NeuroRehabilitation, 37(4), 677–698. https://doi.org/10.3233/NRE- 151285 Rudan, I., Rudan, D., Campbell, H., Carothers, A., Wright, A., Smolej-Narancic, N., Janicijevic, B., Jin, L., Chakraborty, R., Deka, R., & Rudan, P. (2003). Inbreeding and risk of late onset complex disease. Journal of Medical Genetics, 40(12), 925–932. https://doi.org/10.1136/jmg.40.12.925 Ruiz de Sabando, A., Urrutia Lafuente, E., Galbete, A., Ciosi, M., García Amigot, F., García Solaesa, V., Martínez, V. Á., Martinez-Descals, A., Mila, M., Trujillo-Tiebas, M. J., López-Sendón, J. L., Fenollar-Cortés, M., Legarda, I., Noguera, S. B., Millán, J. M., Durán-Herrera, C., Monckton, D. G., & Ramos-Arroyo, M. A. (2022). Spanish HTT gene study reveals haplotype and allelic diversity with possible implications for germline expansion dynamics in Huntington disease . Human Molecular Genetics, 00(September), 1–10. https://doi.org/10.1093/hmg/ddac224 Ruocco, H. H., Lopes-Cendes, I., Li, L. M., Santos-Silva, M., & Cendes, F. (2006). Striatal and extrastriatal atrophy in Huntington’s disease and its relationship with length of the CAG repeat. Brazilian Journal of Medical and Biological Research = Revista Brasileira de Pesquisas Medicas e Biologicas, 39(8), 1129–1136. https://doi.org/10.1590/s0100-879x2006000800016 Saloum de Neves Manta, F., Pereira, R., Vianna, R., Rodolfo Beuttenmüller de Araújo, A., Leite Góes Gitaí, D., Aparecida da Silva, D., de Vargas Wolfgramm, E., da Mota Pontes, I., Ivan Aguiar, J., Ozório Moraes, M., Fagundes de Carvalho, E., & Gusmão, L. (2013). Revisiting the Genetic Ancestry of Brazilians Using Autosomal AIM- Indels. PLoS ONE, 8(9), 1–11. https://doi.org/10.1371/journal.pone.0075145 Salzano, F. M., & Sans, M. (2014). Interethnic admixture and the evolution of Latin American populations. Genetics and Molecular Biology, 37(1 SUPPL. 1), 151–170. https://doi.org/10.1590/S1415-47572014000200003 Sánchez-Castañeda, C., Squitieri, F., Di Paola, M., Dayan, M., Petrollini, M., & Sabatini, U. (2015). The role of iron in gray matter degeneration in huntington’s disease: A magnetic resonance imaging study. Human Brain Mapping, 36(1), 50–66. https://doi.org/10.1002/hbm.22612 Sans, M., Figueiro, G., Ackermann, E., Barreto, I., Egaña, A., Bertoni, B., Poittevin- Gilmet, E., Maytia, D., & Hidalgo, P. C. (2011). Mitochondrial DNA in Basque descendants from the city of Trinidad, Uruguay: Uruguayan- or Basque-like population? Human Biology, 83(1), 55–70. https://doi.org/10.3378/027.083.0104 Say, M. J., Jones, R., Scahill, R. I., Dumas, E. M., Coleman, A., Santos, R. C. D., Justo, D., Campbell, J. C., Queller, S., Shores, E. A., Tabrizi, S. J., & Stout, J. C. (2011a). Visuomotor integration deficits precede clinical onset in Huntington’s disease. Neuropsychologia, 49(2), 264–270. https://doi.org/10.1016/j.neuropsychologia.2010.11.016 Say, M. J., Jones, R., Scahill, R. I., Dumas, E. M., Coleman, A., Santos, R. C. D., Justo, D., Campbell, J. C., Queller, S., Shores, E. A., Tabrizi, S. J., & Stout, J. C. (2011b). Visuomotor integration deficits precede clinical onset in Huntington’s disease. Neuropsychologia, 49(2), 264–270. https://doi.org/10.1016/j.neuropsychologia.2010.11.016 Semaka, A., Kay, C., Doty, C. N., Collins, J. A., Tam, N., & Hayden, M. R. (2013). High frequency of intermediate alleles on Huntington disease-associated haplotypes in British Columbia’s general population. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : The Official Publication of the International Society of Psychiatric Genetics, 162B(8), 864–871. https://doi.org/10.1002/ajmg.b.32193 Shekari Khaniani, M., Aob, P., Ranjouri, M., & Mansoori Derakhsan, S. (2017). Molecular analysis and prevalence of Huntington disease in northwestern Iran. Turkish Journal of Medical Sciences, 47(6), 1880–1884. https://doi.org/10.3906/sag-1510-25 Shoulson, I., & Fahn, S. (1979). Huntington disease: clinical care and evaluation. Neurology, 29(1), 1. Siesling, S., van Vugt, J. P., Zwinderman, K. A., Kieburtz, K., & Roos, R. A. (1998). Unified Huntington’s disease rating scale: a follow up. Movement Disorders : Official Journal of the Movement Disorder Society, 13(6), 915–919. https://doi.org/10.1002/mds.870130609 Simón-Sánchez, J., Martí-Massó, J.-F., Sánchez-Mut, J. V., Paisán-Ruiz, C., Martínez-Gil, A., Ruiz-Martínez, J., Sáenz, A., Singleton, A. B., López de Munain, A., & Pérez-Tur, J. (2006). Parkinson’s disease due to the R1441G mutation in Dardarin: a founder effect in the Basques. Movement Disorders : Official Journal of the Movement Disorder Society, 21(11), 1954–1959. https://doi.org/10.1002/mds.21114 Slutsky, D. A., & Recanzone, G. H. (2001). Temporal and spatial dependency of the ventriloquism effect. Neuroreport, 12(1), 7–10. https://doi.org/10.1097/00001756- 200101220-00009 Snowden, J. S. (2017). The Neuropsychology of Huntington’s Disease. Archives of Clinical Neuropsychology, 32(7), 876–887. https://doi.org/10.1093/arclin/acx086 Sprengelmeyer, R., Young, A. W., Calder, A. J., Karnat, A., Lange, H., Hömberg, V., Perrett, D. I., & Rowland, D. (1996). Loss of disgust: Perception of faces and emotions in Huntington’s disease. Brain, 119(5), 1647–1665. https://doi.org/10.1093/brain/119.5.1647 Squitieri, F., Cannella, M., Simonelli, M., Sassone, J., Martino, T., Venditti, E., Ciammola, A., Colonnese, C., Frati, L., & Ciarmiello, A. (2009). Distinct brain volume changes correlating with clinical stage, disease progression rate, mutation size, and age at onset prediction as early biomarkers of brain atrophy in Huntington’s disease. CNS Neuroscience & Therapeutics, 15(1), 1–11. https://doi.org/10.1111/j.1755- 5949.2008.00068.x Stephens, M., Smith, N. J., & Donnelly, P. (2001). A new statistical method for haplotype reconstruction from population data. American Journal of Human Genetics, 68(4), 978–989. https://doi.org/10.1086/319501 Stoker, T. B., Mason, S. L., Greenland, J. C., Holden, S. T., Santini, H., & Barker, R. A. (2022). Huntington’s disease: diagnosis and management. In Practical neurology (Vol. 22, Issue 1, pp. 32–41). NLM (Medline). https://doi.org/10.1136/practneurol- 2021-003074 Stout, J. C., Paulsen, J. S., Queller, S., Solomon, A. C., Whitlock, K. B., Campbell, J. C., Carlozzi, N., Duff, K., Beglinger, L. J., Langbehn, D. R., Johnson, S. A., Biglan, K. M., & Aylward, E. H. (2011). Neurocognitive signs in prodromal Huntington disease. Neuropsychology, 25(1), 1–14. https://doi.org/10.1037/a0020937 Svetozarskiy, S. N., Kopishinskaya, S. V, Gustov, A. V, Radyuk, M. A., Antonova, V. A., Smetankin, I. G., Svetozarskiy, S. N., Kopishinskaya, S. V, Gustov, A. V, Radyuk, M. A., Antonova, V. A., & Smetankin, I. G. (2015). [Ophthalmic manifestations of Huntington’s disease]. Vestnik oftalmologii, 131(5), 82–86. https://doi.org/10.17116/oftalma2015131582-86 Tabrizi, S. J., Langbehn, D. R., Leavitt, B. R., Roos, R. A., Durr, A., Craufurd, D., Kennard, C., Hicks, S. L., Fox, N. C., Scahill, R. I., Borowsky, B., Tobin, A. J., Rosas, H. D., Johnson, H., Reilmann, R., Landwehrmeyer, B., & Stout, J. C. (2009). Biological and clinical manifestations of Huntington’s disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. The Lancet. Neurology, 8(9), 791–801. https://doi.org/10.1016/S1474-4422(09)70170-X Tabrizi, S. J., Leavitt, B. R., Landwehrmeyer, G. B., Wild, E. J., Saft, C., Barker, R. A., Blair, N. F., Craufurd, D., Priller, J., Rickards, H., Rosser, A., Kordasiewicz, H. B., Czech, C., Swayze, E. E., Norris, D. A., Baumann, T., Gerlach, I., Schobel, S. A., Paz, E., … Lane, R. M. (2019). Targeting Huntingtin Expression in Patients with Huntington’s Disease. The New England Journal of Medicine, 380(24), 2307–2316. https://doi.org/10.1056/NEJMoa1900907 Tan, B., Shishegar, R., Fornito, A., Poudel, G., & Georgiou-Karistianis, N. (2022). Longitudinal mapping of cortical surface changes in Huntington’s Disease. Brain Imaging and Behavior, 16(3), 1381–1391. https://doi.org/10.1007/s11682-021-00625- 2 Tan, B., Shishegar, R., Poudel, G. R., Fornito, A., & Georgiou-Karistianis, N. (2021). Cortical morphometry and neural dysfunction in Huntington’s disease: a review. European Journal of Neurology, 28(4), 1406–1419. https://doi.org/https://doi.org/10.1111/ene.14648 Tishkoff, S. A., & Kidd, K. K. (2004). Implications of biogeography of human populations for “race” and medicine. Nature Genetics, 36(11 Suppl), S21-7. https://doi.org/10.1038/ng1438 Tröster, A. I., Pulaski, S. J., & Woods, S. P. (2019). Neuropsychology of movement disorders and motor neuron disease: Parkinson’s disease, progressive supranuclear palsy, essential tremor, Huntington’s disease, and amyotrophic lateral sclerosis. In Handbook of medical neuropsychology: Applications of cognitive neuroscience, 2nd ed. (pp. 415–440). Springer Nature Switzerland AG. https://doi.org/10.1007/978-3- 030-14895-9_19 Universidad Simón Bolivar. (2021). Enfermedad de Huntington una aproximación desde la investigación. Valdés Hernández, M. D. C., Abu-Hussain, J., Qiu, X., Priller, J., Parra Rodríguez, M., Pino, M., Báez, S., & Ibáñez, A. (2019). Structural neuroimaging differentiates vulnerability from disease manifestation in colombian families with Huntington’s disease. Brain and Behavior, 9(8), e01343. https://doi.org/10.1002/brb3.1343 Vaportzis, E., Georgiou-Karistianis, N., Churchyard, A., & Stout, J. C. (2015). Dual task performance in Huntington’s disease: A comparison of choice reaction time tasks. Neuropsychology, 29(5), 703–712. https://doi.org/10.1037/neu0000172 Vonsattel, J. P., & DiFiglia, M. (1998). Huntington disease. Journal of Neuropathology and Experimental Neurology, 57(5), 369–384. https://doi.org/10.1097/00005072- 199805000-00001 Walker, R. H., Gatto, E. M., Bustamante, M. L., Bernal-Pacheco, O., Cardoso, F., Castilhos, R. M., Chana-Cuevas, P., Cornejo-Olivas, M., Estrada-Bellmann, I., & Jardim, L. B. (2018). Huntington’s disease-like disorders in Latin America and the Caribbean. Parkinsonism & Related Disorders, 53, 10–20. Warby, S. C., Visscher, H., Collins, J. A., Doty, C. N., Carter, C., Butland, S. L., Hayden, A. R., Kanazawa, I., Ross, C. J., & Hayden, M. R. (2011). HTT haplotypes contribute to differences in Huntington disease prevalence between Europe and East Asia. European Journal of Human Genetics, 19(5), 561–566. https://doi.org/10.1038/ejhg.2010.229 wikiwand. (n.d.). Diáspora vasca. Https://Assets.Wikiwand.Com/Img/Logo_new.Svg. Wilson, H., Dervenoulas, G., & Politis, M. (2018). Chapter Nine - Structural Magnetic Resonance Imaging in Huntington’s Disease. In M. Politis (Ed.), Imaging in Movement Disorders: Imaging in Atypical Parkinsonism and Familial Movement Disorders (Vol. 142, pp. 335–380). Academic Press. https://doi.org/https://doi.org/10.1016/bs.irn.2018.09.006 Wolf, R. C., Sambataro, F., Vasic, N., Baldas, E.-M., Ratheiser, I., Bernhard Landwehrmeyer, G., Depping, M. S., Thomann, P. A., Sprengelmeyer, R., Süssmuth, S. D., & Orth, M. (2014). Visual system integrity and cognition in early Huntington’s disease. The European Journal of Neuroscience, 40(2), 2417–2426. https://doi.org/10.1111/ejn.12575 Yeterian, E. H., & Pandya, D. N. (1995). Corticostriatal connections of extrastriate visual areas in rhesus monkeys. The Journal of Comparative Neurology, 352(3), 436–457. https://doi.org/10.1002/cne.903520309 Youn, Y. C., Pyun, J.-M., Ryu, N., Baek, M. J., Jang, J.-W., Park, Y. H., Ahn, S.-W., Shin, H.-W., Park, K.-Y., & Kim, S. Y. (2021). Use of the Clock Drawing Test and the Rey–Osterrieth Complex Figure Test-copy with convolutional neural networks to predict cognitive impairment. Alzheimer’s Research & Therapy, 13(1), 85. https://doi.org/10.1186/s13195-021-00821-8 Zaitlen, N., Kraft, P., Patterson, N., Pasaniuc, B., Bhatia, G., Pollack, S., & Price, A. L. (2013). Using Extended Genealogy to Estimate Components of Heritability for 23 Quantitative and Dichotomous Traits. PLoS Genetics, 9(5). https://doi.org/10.1371/journal.pgen.1003520 Zeun, P., Scahill, R. I., Tabrizi, S. J., & Wild, E. J. (2019). Fluid and imaging biomarkers for Huntington’s disease. Molecular and Cellular Neuroscience, 97, 67–80. https://doi.org/https://doi.org/10.1016/j.mcn.2019.02.004 Zivelin, A., Bauduer, F., Ducout, L., Peretz, H., Rosenberg, N., Yatuv, R., & Seligsohn, U. (2002). Factor XI deficiency in French Basques is caused predominantly by an ancestral Cys38Arg mutation in the factor XI gene. Blood, 99(7), 2448–2454. https://doi.org/10.1182/blood.V99.7.2448 E. M. & A. R. Daza B, Caiaffa RH, Arteta BJV, Echevarría RV, “Estudio neuroepidemiológico enJuandeAcosta,Atlántico,Colombia,” ActaMédCoI, vol. 17, p. 324, 1991.